New York, NY -- (SBWIRE) -- 12/11/2014 -- Diabetes is a chronic disease characterized by high blood sugar level. Diabetes is causes due to improper functioning of pancreas that secretes insulin. Diabetes is also known as diabetes mellitus. High blood sugar results into increased thirst, frequent urination and increased hunger. Lack in treatment for diabetes causes several complications such as diabetes ketoacidosis, heart disease, stroke and kidney failures. Insulin infusion therapy is used to treat diabetes. There are three types of diabetes including type1, type 2 and gestational diabetes. Type 1 diabetes is characterized by low production of insulin by body and it is also known as insulin dependent diabetes or juvenile diabetes. Some of the conditions which lead to type 1 diabetes are addisons disease, celiac disease, rheumatoid arthritis and autoimmune thyroid disease. Type 2 diabetes are most common type of diabetes and is predominant in overweight and obsessed people. Pancreatectomy, chronic pancreatitis and cystic fibrosis are some of the condition which leads to type2 diabetes. Diabetes are treated with the help of diabetes drugs such as insulin, metformin and sulphonylureas. Diabetes drugs helps in avoiding complications and managing level of blood glucose. Some of the drugs used to treat type 2 diabetes are metformin, actos, avandia, lantus subcutaneous and invokana. All drugs are administered orally except insulin, exenatide, liraglutide and pramlintide. Insulin is delivered through insulin delivery devices. Some of the insulin delivery devices are infusion pump, intravenous sets, insulin syringe, insulin pen and jet injectors. Long term acting, intermediate acting, short term acting and rapid acting are some of the types of insulin used to treat diabetes.

Buy Full Report:
http://www.persistencemarketresearch.com/market-research/bric-diabetes-drugs-market.asp

China and India are dominating the BRIC diabetes drug market due to increasing number of diabetes people and increasing aging population. In addition, rising funds for diabetes control is also supporting the growth of the diabetes drugs market in India. Brazil is expected to show lower growth rate due to patient expiry of various diabetes drugs.

In recent time there is increased use of diabetes drugs due to rising prevalence of diabetes in various age groups of people. Increasing aging population, technological advancements and increasing sales of novel drugs are some of the key factors driving the growth of the BRIC diabetes drugs market. In addition, government initiative for diabetes treatment is also fuelling the growth of the BRIC diabetes drugs market. However, high manufacturing cost of drugs and insulin devices is restraining the growth of the BRIC diabetes drugs market. In addition, low awareness among people for diabetes treatment is also restraining the growth of the BRIC diabetes drugs market.

Maintaining safety and security of patients while using diabetes drugs and drug infusion devices could be a challenge for the growth of the BRIC diabetes drugs market. Some of the trends for the BRIC diabetes drugs market are rising uses of personalized drugs. Some of the companies operating in the BRIC diabetes drugs market are Abbott Laboratories, Biocon, Ltd, Eli Lilly and Company, Lupin Ltd and Sun Pharma Industries Ltd. Other companies include Bayer Healthcare AG, Roche Holding AG, Novo Nordisk A/S and Aurobindo Pharma Ltd.

Request Full Toc:
http://www.persistencemarketresearch.com/toc/3888

Key points covered in the report:

1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)

2) The report covers geographic segmentation

North America
Europe
Asia
RoW

3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020

4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.

About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.